Completed NA INTERVENTIONAL 2-arm NCT02987205

Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF

A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra Versus Restylane® for the Correction of Nasolabial Folds

Sponsor: Prollenium Medical Technologies Inc.

Conditions Nasolabial Fold Correction

Interventions Restylane Revanesse Ultra

Updated 9 times since 2017 Last updated: Jan 24, 2018 Started: May 31, 2015 Primary completion: Mar 31, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Nasolabial Fold Correction and is currently completed. Prollenium Medical Technologies Inc. leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Feb 2020 [monthly]

Completed NA

▶ Show 4 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed NA
Sep 2017 — Dec 2017 [monthly]

Completed NA

Status: Withheld → Completed
Feb 2017 — Sep 2017 [monthly]

Withheld NA
Jan 2017 — Feb 2017 [monthly]

Withheld NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prollenium Medical Technologies Inc.

Data source: Prollenium Medical Technologies Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.